Figitumumab (Anti-IGF1R / CD221) | IGF-1R antibody | Read Reviews & Product Use Citations

Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.

Purity & Quality Control

≥99

Choose Selective IGF-1R Inhibitors

Biological Activity

Description	Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.

References
[1] Pavlicek A, et al. Mol Cancer Ther. 2013;12(12):2929-2939.

References

[1] Pavlicek A, et al. Mol Cancer Ther. 2013;12(12):2929-2939.

Product Details

CAS No.	943453-46-1
Molecular Weight	146
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field